Idexx Laboratories
IDEXX Laboratories, Inc. operates as a global developer, manufacturer, and distributor of diagnostic products and services primarily serving the companion animal veterinary, livestock and poultry, water testing, and human medical point-of-care markets. The company's website is www.idexx.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Idexx Laboratories does
In the company’s own words
IDEXX Laboratories, Inc. operates as a global developer, manufacturer, and distributor of diagnostic products and services primarily serving the companion animal veterinary, livestock and poultry, water testing, and human medical point-of-care markets. The company's website is www.idexx.com.
The company operates through three primary reportable segments: Companion Animal Group, Water, and Livestock, Poultry and Dairy, along with an Other segment encompassing human medical diagnostics and out-licensing arrangements. The Companion Animal Group represents the largest segment, providing point-of-care diagnostic instruments and consumables, reference laboratory services, veterinary practice management software, diagnostic imaging systems, and telemedicine consultation services to veterinary clinics worldwide. The Water segment offers microbial testing solutions for drinking water, recreational water, and industrial applications. The Livestock, Poultry and Dairy segment supplies diagnostic tests and herd health management products for livestock producers and dairy operations.
IDEXX maintains a global sales and distribution presence across North America, Europe, Asia Pacific, Africa, Canada, and Latin America, operating approximately 80 reference laboratories worldwide. The company employs thousands of professionals across manufacturing facilities in Maine, Georgia, Tennessee, and international locations including the Netherlands, Switzerland, France, and the United Kingdom. Research and development represents a significant investment, with the company dedicating substantial resources to developing innovative diagnostic technologies and software solutions.
The company's product portfolio includes the IDEXX VetLab suite of point-of-care analyzers, SNAP rapid assay test kits, VetConnect PLUS cloud-based diagnostic management software, ezyVet practice management systems, and water testing products such as Colilert and Colisure. IDEXX incorporates artificial intelligence capabilities into several diagnostic platforms and imaging systems to enhance diagnostic accuracy and workflow efficiency.
Founded in 1983 and incorporated in Delaware, IDEXX has established itself through continuous innovation in veterinary diagnostics and complementary software solutions. The company's competitive advantages include its integrated diagnostic platform combining point-of-care instruments, reference laboratory services, and practice management software, along with proprietary AI-enhanced technologies and extensive customer relationships with veterinary practices globally.
Company details
- Sector
- Health Care
- Industry (SIC)
- Chemicals
- Headquarters
- WESTBROOK, ME
- Fiscal year end
- December
- CIK
- 874716
- SIC
- 2835
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Idexx Laboratories — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Idexx Laboratories · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Idexx Laboratories’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Idexx Laboratories and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Idexx Laboratories's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Idexx Laboratories's last four quarterly filings that the numbers alone won't show?”